Clinical trial NCT04271852: An Experimental Protocol for the Study of Brain Functional Magnetic Resonance Imaging in Female With Urgent Urinary Incontinence
Official title: An Experimental Protocol for the Study of Brain Functional Magnetic Resonance Imaging in Female With Urgent Urinary Incontinence
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Urinary Incontinence, Urge
Lead sponsor: Second Affiliated Hospital of Wenzhou Medical University
Sponsor class: OTHER
Collaborators: name: Northwestern University
First posted: 2020-02-17
Enrollment: 100
Sex: FEMALE
Minimum age (years): 20
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Background: Patients' life quality and physical and mental health are seriously affected by Urgent Urinary Incontinence(UUI). The cause is not clear at present. It has been found that the injury of the prefrontal lobe and damage to the surrounding cerebral cortex leads to significant lower urinary tract dysfunction. Therefore, some scholars believe that urinary axis of the brain exist between the urinary system and the central nervous system, and the two are controlled by each other. Therefore, to study central conduction in patients with UUI and changes of physiology, pathology, brain chemical, brain structure in brain functional area caused by central sensitivity, in particular, changes in urine control cognition and midbrain limbic system (including memory function areas) in the brain, is beneficial to more in-depth understanding of its pathogenesis and treatment options. The Functional Magnetic Resonance Imaging provides a possibility for the study.

Method / design:Taking female UUI patients as target, through questionnaire survey, voiding diary, specialist physique, examination,ultrasonic examination of pelvic floor muscle, urodynamic examination and three sequence magnetic resonance scanning, after analyzing structural image of brian, resting functional images, dispersion tensor image, comparing with the normal control group and the female UUI group, before and after behavioral therapy in patients with UUI, and those who have no urinary incontinence and those who still have urinary incontinence after behavioral treatment, specific brain function biomarkers for female UUI patients are found and the brain function mechanism of the female UUI is to be explored in this project.

Discussion: This study breaks through the traditional limitations on the cause of incontinence.And it is the first time,the mental/behavior indicators of uui patients were combined with fMRI(Functional Magnetic Resonance Imaging) to explore biomarkers of brain and brain structural changes in patients .Then,it is becoming more and more important that the personalized treatment by building a UUI digital model using fMRI.

Detailed description: The study is a randomized controlled trial that study on the mechanism of brain function in women with urgent urinary incontinence by using fMRI. According to the exclusion criteria, 50 healthy volunteers and 50 UUI patients are recruited to carry out the related experimental research.This study had been approved by the Ethics Committee of the second affiliated Hospital of Wenzhou Medical University (No. LCK2019-291) .

1.50 UUI patients and 50 healthy volunteers who meet the inclusion criteria were selected.

(1) Approved by the Scientific Research Ethics Review Committee of the second affiliated Hospital of Wenzhou Medical University, 20- 70 years old female volunteers are recruited by studying advertising, reminding volunteers that the study is recruiting women with well bladder control function through the answer to the relevant questionnaires as a screening tool.

2.1 Healthy volunteers (n=50) should empty thier bladder first ；than they perform a fMRI scan.

2.2 The selected patients (n=50) will be inserted into 8F catheter for urine emptying, determination of bladder pressure and injection of aseptic water. First of all, the subjects empty their urine through the catheter, perform a fMRI scan first, and perform the following cycle module after the first scan is complete:①Paused for 11s ②.Injecting 22ml aquae sterilisata into bladder through catheter (completed in 11s ) ③.Paused for 11s ④.withdraw15ml liquid through catheter (completed in 11s ) , running 1-5 modules in circles until the subject issues a urination signal. With the subject's consent, the above cycle is repeated once, to exclude dropout who will be marked as a failure in the study. The rest of the patients completed the above circulation and patients with urine leakage scan the fMRI again.

3.Every fMRI scan of each subject included in the study will be scanned on GE-Discovery 7503T magnetic resonance machine for three sequences (T1,rsfMRI, DTI). The total scanning time is about 25 minutes. The brain structural image (T1) uses GE BRAVO sequence for about 5 minutes and the specific parameters are as follows:TR/TE=7.7/3.4 ms, Flip angle=12°, FOV=256 mm×256 mm, Resolution=256×256, Slice per volume=176, Slice thickness=1 mm. The rsfMRI(resting-state functional magnetic resonance) uses a single EPI sequence for about 10 minutes and the specific parameters are as follows.TR/TE=2000/30 ms, Flip angle=90°, FOV=220 mm×220 mm, Resolution=64×64, Slice thickness=4 mm, Slices per volume=32, Number of volumes=230. The diffusion tensor image (DTI) uses a single diffusion-weighted spin echo EPI sequence for about 10 minutes and the specific parameters are as follows:TR/TE=8000/80 ms, Flip angle=90°, FOV=256 mm×256 mm, Resolution=128×128, Slice thickness=2 mm, Slices per volume=75. In order to use the latest method to analyze the gray microstructure of the brain,investigators will choose two non-zero b values:b=1000 s/mm2 , with a total of 23 dispersion directions; b = 2000 s/mm2 , with a total of 49 dispersion directions.

4. The 50 UUI patients who completed the above trial will be treated with behavioral therapy for 3 months under the guidance of medical staff. The behavioral therapy includes: (1) changes in the way of life including quit smoking, lose weight, keep a normal bowel movement, drinking water in a regular basis, no coffee and white spirit, don't eat spicy and irritating foods, regular urination and defecation, etc. (2) Bladder training: set a urination schedule, with a short interval of time at first, when feeling urination is urgent, the tension of bladder can be alleviated by slow deep breathing and mental transfer to increase the interval of urination gradually. (3) have pelvic floor muscle exercise by drawing up the anus such as, hold on to exhaust and defecate from the anus. The contraction lasts 3, 5 or 10 seconds. And then completely relax the anus. The relaxation time is equal to the drawing up time of anus with 10 to 15 times per exercise, and3 to 5 times a day.

5.Patients with UUI who completed 3 months' behavioral therapy repeat the above 2 -5 study steps again.

6.Relevant research parameters:Image parameters of brain function:investigators will first get the whole brain voxel image parameters and investigators get local gray matter density in structural image. Local degree will be gotten in functional image while local fractional anisotropy, FA will be gotten in the dispersion tensor image. Then by calculating global gray matter density, global degree and global FA, investigators will get the global variables of the brain function (structural, functional and white matter connection anisotropy) of the participants.

7. Data analysis:①By comparing the image parameters of whole brain function with those of the normal control group (Student t-test group comparison, two tails, p \< 0.05/3=0.017 （family-wise correction）),investigators will verify one of research assumptions, that is, whether the brain of the UUI patient has a significant change in function and structure (structural, functional, and white matter connection anisotropy) as compared to the brain of a normal person; At the same time, By comparing the image parameters of whole brain voxel image parameters with those of the normal control group (student t group comparison，two tails, p \< 0.05, cluster size \> 30 (cluster-wise correction)), investigators find out those specific significantly altered data (questionnaire for quality of life of urinary incontinence I-QOL, FSFI- female sexual function index assessment) that shows significant linear correlation (Pearson Correlation, p \<0.05, with age as covariate) with praxiology where the brain region is a unique biomarker of brain function in patients with UUI. ②UUI patients will be divided into two groups after treatment, that is, the symptoms of urinary incontinence disappeared after treatment (abbreviated as the disappeared) and the urinary incontinence was not relieved after treatment (abbreviated as the the unrelieved). Through comparing the image parameters (F-test one-way ANOVA，two tails, p \< 0.05/3=0.017 (family-wise correction))，of whole brain function among the three groups (normal control group, the disappeared group and unrelieved group), investigators will verify the second hypothesis, that is, for patients with UUI whose symptoms of urinary incontinence disappear after behavioral therapy, whether the function and structure of the brain (structural, functional and white matter connectivity) will change reversibly and return to its original state;

③ Through analysis of changes in behavioral data before and after treatment (questionnaire for quality of life of urinary incontinence I-QOL, FSFI- female sexual function index assessment) and linear correlation analysis of all-brain functional image parameters (Pearson Correlation, p \< 0.05, age as covariate), investigators can verify the third hypothesis, that is, the degree of unrelieved urinary incontinence after UUI behavior therapy is significantly correlated with his / her brain function and structural changes.

8.Data analysis tools:FSL software will be applied for brain function image analysis, and MATLAB and SPSS for data statistical analysis.

Eligibility criteria: Inclusion Criteria:

* People in the group should meet the following inclusion criteria:

  * 20-70 years old, medical history ≥ 3 months.
  * According to International Continence Society, ICS, people in the group should be patients diagnosed with UUI.

Exclusion Criteria:

* Exclusion standards should be met by both patient group and the control group ( Not included in if meeting one of the following items ):

  * Scan contraindication ：（1）reactive metal.(2)cardiac pacemaker.(3)magnetic implantation.(3)no spring steel wire in eyelid.(4)artificial cochlea.(5)electrodes/wires, pregnancy, etc.
  * Patients with severe organ diseases ：·（1）liver disease.(2)lung disease.(3)kidney disease.(4)Other diseases that may interfere with the effectiveness and safety assessment of the test or may place the patient at some particular risk.
  * People who is unable to cooperate with each other.
  * A neurological or other medical disease that affects the function of the central nervous system ：（1） anemia.（2） vitamin B12 deficiency .（3）folic acid deficiency.
  * People who abuse drug.
  * People who has dependence history
  * Hyperthyroidism in active period
  * cerebrovascular disease (e.g. transient ischemic attack, ischemic or hemorrhagic stroke, aneurysm)
  * Central nervous system infection
  * Alcoholic dementia
  * Uncontrolled epilepsy
  * Autoimmune disease
  * Diabetes mellitus
  * Detrusor hyperreflexia (cystitis, tuberculosis, tumor, stone, bladder outlet obstruction) and other organic lesion.

Primary outcomes:
measure: Assessing change of the number of leakages was used to assess the severity of urinary incontinence.
timeFrame: Baseline,3th month
measure: Brain regional gray matter density change of subjects
timeFrame: Baseline,3th month
measure: Brain functional connectivity strength
timeFrame: Baseline,3th month
Secondary outcomes:
measure: Assessing change of POP-Q measurements were used to assess pelvic floor prolapse.
timeFrame: Baseline,3th month
measure: Assessing change of the number of millimeters of rectocele used to evaluate the prolapse of the posterior wall of the vagina.
timeFrame: Baseline,3th month
measure: Assessing change of the number of millimeters of prolapse used to assess the extent of prolapse.
timeFrame: Baseline,3th month
measure: Assessing change of the measurement of detrusor compliance was used to assist in the evaluation of acute incontinence.（By Urodynamic examination）
timeFrame: Baseline,3th month
measure: Assessing change of Bladder neck mobility, used to assess the presence of stress urinary incontinence.
timeFrame: Baseline,3th month
measure: Assessing change of the number of millimeters of cystocele used to evaluate the prolapse of the anterior wall of the vagina.
timeFrame: Baseline,3th month
Other outcomes:
measure: Positive and negative mood effect of subject
timeFrame: Baseline,3th month
measure: PISQ-12 change of subjects
timeFrame: Baseline,3th month
measure: I-QOL change of subjects
timeFrame: Baseline,3th month
measure: FSFI change of subjects
timeFrame: Baseline,3th month
measure: SF-12 change of subjects
timeFrame: Baseline,3th month
measure: The severity of depression of subjects
timeFrame: Baseline,3th month
measure: PFID-20 change of subjects
timeFrame: Baseline,3th month
Locations:
city: Wenzhou
country: China
facility: Department of Gynecology of Second Affiliated Hospital of Wenzhou Medical University
state: Zhejiang
Study officials:
References: